Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 051852/0526 | |
| Pages: | 2 |
| | Recorded: | 11/26/2019 | | |
| Attorney Dkt #: | 34323-39187/US |
| Conveyance: | CONFIRMATORY LICENSE |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
|
Issue Dt:
|
01/21/2020
|
Application #:
|
15283887
|
Filing Dt:
|
10/03/2016
|
|
Publication #:
|
|
Pub Dt:
|
04/06/2017
| | | | |
|
Title:
|
TREATMENT OF FOCAL SEGMENTAL GLOMERULAR SCLEROSIS (FSGS) USING THERAPEUTICALLY EFFECTIVE ORAL DOSES OF 10-NITRO-9(E)-OCTADEC-9-ENOIC ACID
|
|
|
Assignee
|
|
|
|
|
| NIH DIVISION OF EXTRAMURAL INVENTIONS AND TECHNOLOGY RESOURCES (DEITR) |
| 6705 ROCKLEDGE DRIVE, SUITE 310, MSC 7980 |
| BETHESDA, MARYLAND 20892-7980 |
|
|
Correspondence name and address
|
| |
GLENN J. FOULDS
|
| |
801 CALIFORNIA STREET
|
| |
FENWICK & WEST LLP
|
| |
MOUNTAIN VIEW, CA 94041
|
Search Results as of:
06/06/2024 03:45 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
